The MuSC-19 study: The Egyptian cohort

This publication has 19 references indexed in Scilit:

• Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
  JAMA Neurology, 2020
• COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
  Multiple Sclerosis and Related Disorders, 2020
• Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia
  JAMA Neurology, 2020
• Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
  Frontiers in Neurology, 2020
• COVID‐19 is a Real Headache!
  Headache: The Journal of Head and Face Pain, 2020
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  Cell, 2020
• Disease-modifying therapies and infectious risks in multiple sclerosis
  Nature Reviews Neurology, 2016
• Impact of sphingosine 1-phosphate modulation on immune outcomes
  Neurology, 2011
• Multiple organ infection and the pathogenesis of SARS
  Journal of Experimental Medicine, 2005
• Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
  The Journal of Pathology, 2004